1 terminated, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Blanchette Rockefeller Neurosciences Insitute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease Bryostatin 1, Placebo - Alzheimer's Disease | Phase 1 / Phase 2 | Terminated | Neurotrope Bioscience, Inc. | 9 | 2014-06-01 | 2017-11-06 |
| Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease Bryostatin for Injection, Placebo - Alzheimer's Disease | Phase 2 | Unknown | Blanchette Rockefeller Neurosciences Insitute | 9 | 2008-04-01 | 2008-02-01 |
bryostatin 1 (2) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Bryostatins (1) · Injections (1) · Sodium Chloride (1)
United States (2)